可溶性环氧化物水解酶抑制剂的降血糖功效研究

doi:10.16431/j.cnki.1671-7236.2017.11.007

《中国畜牧兽医》 ›› 2017, Vol. 44 ›› Issue (11): 3149-3155.doi: 10.16431/j.cnki.1671-7236.2017.11.007

可溶性环氧化物水解酶抑制剂的降血糖功效研究

高婉婷¹, 明亮¹, 何静¹, 白娜¹, 郭雁¹, 伊日贵¹, 吉日木图^1,2

1. 内蒙古农业大学乳品生物技术与工程教育部重点实验室, 呼和浩特 010018;
2. 内蒙古骆驼研究院, 巴丹吉林 737300

收稿日期:2017-06-26 出版日期:2017-11-20 发布日期:2017-11-21
通讯作者: 吉日木图 E-mail:yeluotuo1999@vip.163.com
作者简介:高婉婷(1992-),女,吉林人,硕士生,研究方向:农产品加工及贮藏,E-mail:15248116813@163.com
基金资助:
国家自然科学基金项目（31360397）；国际科技合作项目（2015DFR30680、ky201401002）；内蒙古重大专项

Hypoglycemic Effect of Soluble Epoxide Hydrolase Inhibitors on Diabetic Mice

GAO Wan-ting¹, MING Liang¹, HE Jing¹, BAI Na¹, GUO Yan¹, YI Ri-gui¹, Jirimutu^1,2

1. Key Laboratory of Dairy Biotechnology and Bioengineering, Ministry of Education, Inner Mongolia Agricultural University, Hohhot 010018, China;
2. Camel Protection Association of Inner Mongolia, Badajilin 737300, China

Received:2017-06-26 Online:2017-11-20 Published:2017-11-21

摘要/Abstract

摘要：

为探究可溶性环氧化物水解酶抑制剂（soluble epoxide hydrolase inhibitors，sEHI）的降血糖功效，试验以高脂饲料与链脲佐菌素（streptozotocin，STZ）联合诱导的Ⅱ型糖尿病小鼠为研究对象，将C57BL/6J小鼠随机分为：正常对照组、糖尿病模型组和sEHI组，sEHI组饲喂高脂饲料，每日灌胃sEHI （t-AUCB）1 mg/kg，连续灌胃4周；糖尿病模型组饲喂高脂饲料，每日灌胃同等计量的生理盐水；正常对照组饲喂普通饲料，每日灌胃同等体积的生理盐水。期间各组小鼠均自由采食及饮水，记录小鼠体重、血糖并进行口服葡萄糖耐量试验。试验结束后，测定血清血脂指标、肝脏过氧化指标并对小鼠胰岛组织进行病理学分析。结果显示，与糖尿病模型组相比，采用sEHI干预后糖尿病小鼠的空腹血糖显著降低（P<0.05），而葡萄糖耐量水平升高；小鼠血清总胆固醇（TC）、甘油三酯（TG）、低密度脂蛋白（LDL）水平明显降低，其中TC、TG水平与糖尿病模型组相比差异显著（P<0.05），而高密度脂蛋白与胆固醇比值（HDL/TC）水平则显著升高（P<0.05）；与糖尿病模型组相比，sEHI干预组小鼠肝脏的超氧化物歧化酶（SOD）、过氧化氢酶（CAT）活性显著提高（P<0.05），丙二醛（MDA）活性显著降低（P<0.05）；小鼠的胰岛组织切片分析结果表明，sEHI对小鼠胰岛组织有明显的修复作用。综上所述，sEHI具有降血糖、减轻自由基损伤、抑制脂质过氧化、修复受损胰岛组织的作用。

关键词: Ⅱ型糖尿病; 可溶性环氧化物水解酶抑制剂; 降血糖; 血脂指标

Abstract:

In order to study the hypoglycemic effect of soluble epoxide hydrolase inhibitors (sEHI) on diabetic mice,the diabetic mice model were successfully induced by high-fat diet and streptozotocin (STZ). The diabetic mice (C57BL/6J) were randomly divided into three groups,including normal control group,diabetic control group and sEHI group,the mice in three groups were fed high-fat diet+1 mg/kg sEHI (t-AUCB),high-fat diet+same volume normal saline,normal diet+same volume normal saline,respectively,and intervention last for 4 weeks. During the experiment,the body weight,blood glucose were recorded,and performed oral glucose tolerance test was conducted. After the experiment,indicators of serum lipids,liver peroxidation and pathological analysis of pancreatic tissue were measured. The results showed that compared with diabetic control group,the fasting blood glucose of mice in sEHI group was significantly reduced (P<0.05),and their glucose tolerance was improved. And the TC (P<0.05),TG (P<0.05) and LDL (P>0.05) in sEHI group were decreased,while the LDL/TC was significantly increased (P<0.05).The SOD and CAT activity in liver of diabetic mice treated with sEHI were significantly increased (P<0.05) and MDA activity was significantly decreased (P<0.05).Based on mouse pancreatic tissue sections,we speculated that sEHI had ability to repair activity on damaged islet tissue. In conclusion,the sEHI could reduce the blood glucose level and the free radical damage,inhibit lipid peroxidation,repair of damaged islet tissue in mice.

Key words: type Ⅱ diabetes; soluble epoxide hydrolase inhibitors (sEHI); antidiabetics; serum lipid parameter

中图分类号:

R587.1

高婉婷, 明亮, 何静, 白娜, 郭雁, 伊日贵, 吉日木图. 可溶性环氧化物水解酶抑制剂的降血糖功效研究[J]. 《中国畜牧兽医》, 2017, 44(11): 3149-3155.

GAO Wan-ting, MING Liang, HE Jing, BAI Na, GUO Yan, YI Ri-gui, Jirimutu. Hypoglycemic Effect of Soluble Epoxide Hydrolase Inhibitors on Diabetic Mice[J]. , 2017, 44(11): 3149-3155.

参考文献

[1] Shamseddeen H,Getty J Z,Hamdallah I N,et al. Epidemiology and economic impact of obesity and type 2 diabetes[J].Surgical Clinics of North America,2011,91(6):1163-1172.
[2] Whiting D R,Guariguata L,Weil C,et al. IDF diabetes atlas:Global estimates of the prevalence of diabetes for 2011 and 2030[J]. Diabetes Research and Clinical Practice,2011,94(3):311-321.
[3] 何静,乌云额尔敦,吉日木图,等.环氧二十碳三烯酸生物学作用机制的研究进展[J].中国畜牧兽医,2016,43(3):700-706.
[4] Xu X,Zhao C X,Wang L,et al. Increased CYP2J3 expression reduces insulin resistance in fructose-treated rats and db/db mice[J].Diabetes,2010,59(4):997-1005.
[5] Spector A A,Norris A W. Action of epoxyeicosatrienoic acids on cellular function[J].American Journal of Physiology Cell Physiology,2007,292(3):996.
[6] Morisseau C,Hammock B D.Impact of soluble epoxide hydrolase and epoxyeicosanoids on human health[J]. Annual Review of Pharmacology and Toxicology,2013,53:37-58.
[7] Shen H C,Hammock B D. Discovery of inhibitors of soluble epoxide hydrolase:A target with multiple potential therapeutic indications[J].Journal of Medicinal Chemistry,2012,55(5):1789-1808.
[8] Mao P,Zhao M,Zhang F,et al.Phase separation induced molecular fractionation of gum arabic-sugar beet pectin systems[J].Carbohydrate Polymers,2013,98(1):699-705.
[9] Furman B L.Streptozotocin-induced diabetic models in mice and rats[J].Current Protocols in Pharmacology,2015,70:47.
[10] 张金保,庄朋伟,林映雪,等.小鼠品系、给药剂量及次数对链脲霉素诱导Ⅰ型糖尿病的影响[J].中国现代医学杂志,2013,23(36):31-35.
[11] 伍静,王彬,鲍臻,等.糖尿病动物模型的特点及影响因素分析[J].现代生物医学进展,2013,13(25):4988-4990.
[12] Chen L,Cheng F,Yi Z,et al. Beneficial effects of inhibition of soluble epoxide hydrolase on glucose homeostasis and islet damage in a streptozotocin-induced diabetic mouse model[J].Prostaglandins & Other Lipid Mediators,2013,104-105:42-48.
[13] 李瑞.细胞色素P450表氧化酶2J2基因过表达通过抑制肝脏炎症改善2型糖尿病[D].武汉:华中科技大学,2012.
[14] McGarry J D.Banting lecture 2001 dysregulation of fatty acid metabolism in the etiology of type 2 diabetes[J].Diabetes,2002,51(1):7.
[15] 魏巍,左云飞,李铭志,等.Ⅱ型糖尿病、冠心病、脑梗塞患者血脂、载脂蛋白和脂蛋白(a)的检测及其意义[J].大连医科大学学报,2003,25(3):210-212.
[16] 张洁.细胞色素P450表氧化酶2J2基因过表达及与可溶性环氧化酶水解酶抑制剂共同作用治疗小鼠2型糖尿病的作用及其机制[D].武汉:华中科技大学,2012.
[17] 李飞. 豆渣及其蛋白、膳食纤维对2型糖尿病的干预作用及其机制研究[D].武汉:华中农业大学,2015.
[18] Maritim A C, Sanders R A,Watkins J B. Diabetes,oxidative stress,and antioxidants:A review[J].Journal of Biochemical and Molecular Toxicology,2003,17(1):24-38.
[19] 王兴旭.细胞色素P450表氧化酶2J2基因过表达治疗小鼠心力衰竭的作用及其机制[D].武汉:华中科技大学, 2013.
[20] Luria A,Bettaieb A,Xi Y,et al. Soluble epoxide hydrolase deficiency alters pancreatic islet size and improves glucose homeostasis in a model of insulin resistance[J].Proceedings of the National Academy of Sciences of the United States of America,2011,108(22):9038-9043.
[21] Shen H C. Soluble epoxide hydrolase inhibitors:A patent review[J].Expert Opinion on Therapeutic Patents,2010,20(7):941.
[22] Luo P,Chang H H,Zhou Y,et al.Inhibition or deletion of soluble epoxide hydrolase prevents hyperglycemia,promotes insulin secretion,and reduces islet apoptosis[J].Journal of Pharmacology & Experimental Therapeutics,2010,334(2):430-438.

可溶性环氧化物水解酶抑制剂的降血糖功效研究

Hypoglycemic Effect of Soluble Epoxide Hydrolase Inhibitors on Diabetic Mice

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 1

编辑推荐

Metrics

本文评价